Cargando…

Exocrine pancreatic function is preserved in systemic sclerosis

BACKGROUND: Systemic sclerosis (SSc) has been suggested to cause exocrine pancreatic dysfunction. However, a case-control-based autopsy study failed to associate systemic sclerosis with any pancreatic histopathology. The primary objective of this study was to examine the exocrine pancreatic function...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozovic, Gracijela, Pullerits, Rille, Ståhl, Arne, Ydström, Kristina, Wenger, Daniel, Marsal, Jan, Thulin, Pontus, Andréasson, Kristofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373050/
https://www.ncbi.nlm.nih.gov/pubmed/30755261
http://dx.doi.org/10.1186/s13075-019-1840-z
_version_ 1783394891680710656
author Bozovic, Gracijela
Pullerits, Rille
Ståhl, Arne
Ydström, Kristina
Wenger, Daniel
Marsal, Jan
Thulin, Pontus
Andréasson, Kristofer
author_facet Bozovic, Gracijela
Pullerits, Rille
Ståhl, Arne
Ydström, Kristina
Wenger, Daniel
Marsal, Jan
Thulin, Pontus
Andréasson, Kristofer
author_sort Bozovic, Gracijela
collection PubMed
description BACKGROUND: Systemic sclerosis (SSc) has been suggested to cause exocrine pancreatic dysfunction. However, a case-control-based autopsy study failed to associate systemic sclerosis with any pancreatic histopathology. The primary objective of this study was to examine the exocrine pancreatic function in consecutive SSc patients in relation to an age- and sex-matched control group. A secondary objective was to relate exocrine pancreatic function to radiological, laboratory, and clinical SSc characteristics. METHODS: One hundred twelve consecutive patients fulfilling the 2013 American Congress of Rheumatology/European League Against Rheumatism criteria for SSc and 52 control subjects were matched for sex and age. Exocrine pancreatic function was assessed by ELISA-based measurement of fecal elastase, and levels ≤ 200 μg/g were considered pathological, i.e., representing exocrine pancreatic insufficiency. Patients were characterized regarding SSc manifestations including gastrointestinal and hepatobiliary function, by use of laboratory and clinical examinations. Pancreas parenchyma characteristics were evaluated by high-resolution computer tomography (HRCT). RESULTS: A similar proportion of subjects exhibited pathological levels of fecal elastase among SSc patients (6/112; 5.4%) and control subjects (3/52; 5.8%). Patients with fecal elastase ≤ 200 μg/g did not differ from other SSc patients with respect to laboratory and clinical characteristics, including malnutrition. SSc subjects with low levels of fecal elastase displayed significantly lower pancreas attenuation on HRCT examinations compared to the control subjects. CONCLUSIONS: In this study encompassing 112 consecutive SSc patients and 52 matched control subjects, we were unable to associate systemic sclerosis with clinically significant exocrine pancreatic dysfunction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1840-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6373050
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63730502019-02-25 Exocrine pancreatic function is preserved in systemic sclerosis Bozovic, Gracijela Pullerits, Rille Ståhl, Arne Ydström, Kristina Wenger, Daniel Marsal, Jan Thulin, Pontus Andréasson, Kristofer Arthritis Res Ther Research Article BACKGROUND: Systemic sclerosis (SSc) has been suggested to cause exocrine pancreatic dysfunction. However, a case-control-based autopsy study failed to associate systemic sclerosis with any pancreatic histopathology. The primary objective of this study was to examine the exocrine pancreatic function in consecutive SSc patients in relation to an age- and sex-matched control group. A secondary objective was to relate exocrine pancreatic function to radiological, laboratory, and clinical SSc characteristics. METHODS: One hundred twelve consecutive patients fulfilling the 2013 American Congress of Rheumatology/European League Against Rheumatism criteria for SSc and 52 control subjects were matched for sex and age. Exocrine pancreatic function was assessed by ELISA-based measurement of fecal elastase, and levels ≤ 200 μg/g were considered pathological, i.e., representing exocrine pancreatic insufficiency. Patients were characterized regarding SSc manifestations including gastrointestinal and hepatobiliary function, by use of laboratory and clinical examinations. Pancreas parenchyma characteristics were evaluated by high-resolution computer tomography (HRCT). RESULTS: A similar proportion of subjects exhibited pathological levels of fecal elastase among SSc patients (6/112; 5.4%) and control subjects (3/52; 5.8%). Patients with fecal elastase ≤ 200 μg/g did not differ from other SSc patients with respect to laboratory and clinical characteristics, including malnutrition. SSc subjects with low levels of fecal elastase displayed significantly lower pancreas attenuation on HRCT examinations compared to the control subjects. CONCLUSIONS: In this study encompassing 112 consecutive SSc patients and 52 matched control subjects, we were unable to associate systemic sclerosis with clinically significant exocrine pancreatic dysfunction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1840-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-12 2019 /pmc/articles/PMC6373050/ /pubmed/30755261 http://dx.doi.org/10.1186/s13075-019-1840-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bozovic, Gracijela
Pullerits, Rille
Ståhl, Arne
Ydström, Kristina
Wenger, Daniel
Marsal, Jan
Thulin, Pontus
Andréasson, Kristofer
Exocrine pancreatic function is preserved in systemic sclerosis
title Exocrine pancreatic function is preserved in systemic sclerosis
title_full Exocrine pancreatic function is preserved in systemic sclerosis
title_fullStr Exocrine pancreatic function is preserved in systemic sclerosis
title_full_unstemmed Exocrine pancreatic function is preserved in systemic sclerosis
title_short Exocrine pancreatic function is preserved in systemic sclerosis
title_sort exocrine pancreatic function is preserved in systemic sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373050/
https://www.ncbi.nlm.nih.gov/pubmed/30755261
http://dx.doi.org/10.1186/s13075-019-1840-z
work_keys_str_mv AT bozovicgracijela exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT pulleritsrille exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT stahlarne exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT ydstromkristina exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT wengerdaniel exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT marsaljan exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT thulinpontus exocrinepancreaticfunctionispreservedinsystemicsclerosis
AT andreassonkristofer exocrinepancreaticfunctionispreservedinsystemicsclerosis